RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma.
Saved in:
| Title: | RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma. |
|---|---|
| Authors: | Xu H; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Lee S; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Leser F; Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Fedorova O; Department of Molecular, Cellular and Developmental Biology, Yale University School of Medicine, New Haven, CT, USA., Lu P; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Song E; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA., Touat M; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute (ICM), Inserm U1127, CNRS UMR 7225, Service de Neuro-oncologie, Hôpital Pitié-Salpêtrière, Paris, France., Eichmann A; Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.; Paris Cardiovascular Research Center, Inserm U970, Université Paris, Paris, France., Iwasaki A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Center for Infection and Immunity, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Pyle AM; Department of Molecular, Cellular and Developmental Biology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Department of Chemistry, Yale University, New Haven, CT 06511, USA., Thomas JL; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute (ICM), Inserm U1127, CNRS UMR 7225, Service de Neuro-oncologie, Hôpital Pitié-Salpêtrière, Paris, France. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Jan 08. Date of Electronic Publication: 2026 Jan 08. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41542495 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Leser+F%22">Leser F</searchLink>; Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Fedorova+O%22">Fedorova O</searchLink>; Department of Molecular, Cellular and Developmental Biology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Lu+P%22">Lu P</searchLink>; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Song+E%22">Song E</searchLink>; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Touat+M%22">Touat M</searchLink>; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute (ICM), Inserm U1127, CNRS UMR 7225, Service de Neuro-oncologie, Hôpital Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Eichmann+A%22">Eichmann A</searchLink>; Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.; Paris Cardiovascular Research Center, Inserm U970, Université Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Iwasaki+A%22">Iwasaki A</searchLink>; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Center for Infection and Immunity, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.<br /><searchLink fieldCode="AU" term="%22Pyle+AM%22">Pyle AM</searchLink>; Department of Molecular, Cellular and Developmental Biology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Department of Chemistry, Yale University, New Haven, CT 06511, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+JL%22">Thomas JL</searchLink>; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute (ICM), Inserm U1127, CNRS UMR 7225, Service de Neuro-oncologie, Hôpital Pitié-Salpêtrière, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2026 Jan 08. <i>Date of Electronic Publication: </i>2026 Jan 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41542495 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.64898/2026.01.07.698153 Languages: – Code: eng Text: English Titles: – TitleFull: RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Lee S – PersonEntity: Name: NameFull: Leser F – PersonEntity: Name: NameFull: Fedorova O – PersonEntity: Name: NameFull: Lu P – PersonEntity: Name: NameFull: Song E – PersonEntity: Name: NameFull: Touat M – PersonEntity: Name: NameFull: Eichmann A – PersonEntity: Name: NameFull: Iwasaki A – PersonEntity: Name: NameFull: Pyle AM – PersonEntity: Name: NameFull: Thomas JL IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 01 Text: 2026 Jan 08 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |